U.S. Wireless Telecom Stock News

NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Is It Time To Reassess Ichor Holdings (ICHR) After Its Strong Year To Date Rally?

If you are wondering whether Ichor Holdings at US$46.83 is offering value or asking you to pay up for the story, this breakdown is designed to help you separate price from worth. The stock has had a mixed shorter term pattern, with a 13.0% return over the last 7 days, a 2.1% decline over 30 days, a 129.4% return year to date, and a 76.0% return over 1 year, while the 3 year and 5 year figures sit at 54.8% and a 9.3% decline respectively. These moves sit against a backdrop of ongoing interest...
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

Canadian Solar (CSIQ) Q4 EPS Loss Reinforces Bearish Margin Narrative

Canadian Solar (CSIQ) has capped FY 2025 with fourth quarter revenue of US$1.2 billion and a basic EPS loss of US$1.28, as net income excluding extra items came in at a loss of US$86.3 million, putting the spotlight firmly on profitability rather than top line scale. Over recent quarters, the company has seen revenue move between US$1.2 billion and US$1.7 billion, with basic EPS swinging from a profit of US$0.51 in Q4 2024 to a loss in Q4 2025. This sets up a results season where margin...
NYSE:SFBS
NYSE:SFBSBanks

A Look At ServisFirst Bancshares (SFBS) Valuation After Recent Share Price Weakness

What recent returns say about ServisFirst Bancshares ServisFirst Bancshares (SFBS) has delivered mixed share price performance, with a flat move over the past day, a 1.1% decline over the past week, a 15.2% decline over the past month, and a 0.5% decline over the past 3 months. See our latest analysis for ServisFirst Bancshares. The recent 15.2% one month share price decline sits against a broadly flat year to date share price return of 0.7%. At the same time, the 1 year total shareholder...
NYSE:ASB
NYSE:ASBBanks

Is Associated Banc-Corp’s (ASB) Milwaukee Leadership Shift Reframing Its Local vs National Growth Focus?

Associated Banc-Corp recently announced a leadership transition in its Milwaukee market, with senior vice president Neil Riegelman becoming Milwaukee market president on April 1, 2026, while former market president John Utz concentrates on expanding the bank’s nationally focused specialty businesses. This shift separates local market leadership from the oversight of specialty lines, potentially sharpening focus on commercial growth in Southern Wisconsin while aligning executive attention...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

Alumis (ALMS) Q4 Loss Of US$92.9 Million Tests Bullish Growth Narrative

Alumis (ALMS) has just wrapped up FY 2025 with Q4 revenue of US$1.9 million, a basic EPS loss of US$0.89 per share, and a net loss of US$92.9 million. On a trailing twelve month basis, revenue was US$24.1 million, with a basic EPS loss of US$2.86 per share and a net loss of US$243.3 million. Over recent quarters, revenue moved from US$17.4 million in Q1 2025 to US$2.7 million in Q2, US$2.1 million in Q3, and US$1.9 million in Q4. EPS shifted from a loss of US$1.82 in Q1 to a profit of US$0.78...
NYSE:FBIN
NYSE:FBINBuilding

Fortune Brands Leadership Shakeup And Activist Deal Test Turnaround Prospects

Fortune Brands Innovations (NYSE:FBIN) has appointed an interim CEO and an interim CFO while launching a formal search for a permanent chief executive. The company reached a governance cooperation agreement with activist investor Ed Garden, who has joined the board of directors. The board plans to phase out its classified structure, following internal leadership changes and shareholder pressure that appear aimed at avoiding a proxy fight. For investors watching NYSE:FBIN, these leadership...
NasdaqGS:PCVX
NasdaqGS:PCVXBiotechs

Assessing Vaxcyte (PCVX) Valuation After Strong VAX 31 Phase 1/2 Results In The Lancet

Vaxcyte (PCVX) is back in focus after publishing VAX-31 Phase 1/2 results in The Lancet Infectious Diseases. The data show favorable safety and immune responses versus Prevnar 20 and support progression into broad Phase 3 trials. See our latest analysis for Vaxcyte. The VAX-31 update comes after a mixed period for investors, with a 90-day share price return of 17.73% and a 1-year total shareholder return decline of 26.8%, while the 5-year total shareholder return of 130.01% points to stronger...
NasdaqGS:ASMB
NasdaqGS:ASMBBiotechs

Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives

Assembly Biosciences (ASMB) just closed FY 2025 with Q4 revenue of US$42.5 million and basic EPS of US$1.30, alongside trailing twelve month revenue of US$72.3 million and a trailing EPS loss of US$0.55. Over recent quarters the company has seen revenue move from US$7.4 million and an EPS loss of US$1.58 in Q4 FY 2024 to US$42.5 million and EPS of US$1.30 in Q4 FY 2025, while trailing twelve month net income narrowed to a loss of US$6.1 million. This sets up a results season where investors...
NYSEAM:GROY
NYSEAM:GROYMetals and Mining

Gold Royalty’s Cash Flow Turnaround Tests Market Pullback And Valuation Gap

Gold Royalty (NYSEAM:GROY) recently reported three consecutive quarters of positive free cash flow, which management has described as a financial inflection point. The company reported record annual revenue and cash flow, alongside a shift to a zero-debt capital structure after equitizing debt and completing a major equity raise. Gold Royalty expanded its portfolio with a new royalty on BHP's Pedra Branca mine, adding exposure to an operating asset. Gold Royalty, which last closed at $3.15,...
NYSE:DINO
NYSE:DINOOil and Gas

HF Sinclair Dual Executive Exit Puts Governance And Valuation In Focus

HF Sinclair plans a permanent separation with its CEO and CFO following their voluntary leaves. The company is working toward final separation agreements as part of an ongoing internal review. The dual executive exit comes during a period of growth that includes joint ventures and other initiatives. For HF Sinclair (NYSE:DINO), this leadership change comes at a time when the stock has seen strong recent performance, with shares at $60.22 and a 28.5% return year to date. The stock is up 8.1%...
NYSE:EQR
NYSE:EQRResidential REITs

A Look At Equity Residential’s (EQR) Valuation After Recent Share Price Weakness

Equity Residential (EQR) is back on investor radars after recent trading weakness, with the stock showing a negative month and past 3 months return while operating a large US apartment portfolio. See our latest analysis for Equity Residential. At a latest share price of US$57.98, Equity Residential’s recent 1 month share price return of 8.82% and 1 year total shareholder return of 13.42% suggest pressure on momentum, despite a positive 3 year total shareholder return of 15.87%. If you are...
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

Is It Time To Revisit First Financial Bancorp (FFBC) After The Recent Share Price Pullback?

Wondering if First Financial Bancorp at around US$26.70 is still offering value or if most of the upside has already been priced in? This article breaks down what the numbers say about the stock. The share price closed at US$26.70, with a 0.8% slip over the past week and an 11.6% decline over the last month, while still showing 6.4% year to date returns and 12.1% over the past year. Recent coverage around First Financial Bancorp has focused on its position within the US banking sector and...
NYSE:DOV
NYSE:DOVMachinery

A Look At Dover (DOV) Valuation After Recent Share Price Volatility

Why Dover (DOV) May Be On Your Radar Today Dover (DOV) has drawn fresh attention after recent share price swings, with the stock closing at $209.37 and showing mixed moves over the past week, month, and past 3 months. Investors may now be reassessing its long term track record and current fundamentals. See our latest analysis for Dover. For context, Dover’s 1 year total shareholder return of 17.82% and 3 year total shareholder return of 53.38% contrast with a recent 30 day share price return...
NYSE:TWO
NYSE:TWOMortgage REITs

A Look At Two Harbors Investment (TWO) Valuation After Recent Share Price Rebound And Longer Term Weakness

Recent performance snapshot Two Harbors Investment (TWO) has seen mixed recent performance, with a 19.4% gain over the past week contrasting with a 4.3% decline over the past month and a 6.1% decline over the past 3 months. See our latest analysis for Two Harbors Investment. Looking beyond the recent rebound, the 1-year total shareholder return of a 10.2% decline alongside a 5-year total shareholder return of a 29.71% decline suggests that momentum has been fading, even as the latest 7-day...
NYSE:ZKH
NYSE:ZKHTrade Distributors

ZKH Group (NYSE:ZKH) Turns Quarterly Profit As Loss Reduction Narrative Faces New Test

ZKH Group (NYSE:ZKH) closed FY 2025 with fourth quarter revenue of C¥2,557.2 million and basic EPS of C¥0.03, set against trailing twelve month revenue of C¥8,987.7 million and a net loss of C¥139.7 million. Over the past six reported quarters, revenue has ranged between C¥1,935.4 million and C¥2,557.2 million, while basic EPS has moved from a loss of C¥0.50 in Q3 2024 to a small profit in Q4 2025. This leaves investors focused on how efficiently that top line is translating into earnings...
NYSE:FN
NYSE:FNElectronic

A Look At Fabrinet (FN) Valuation As iPronics Partnership Expands AI Data Center Role

Fabrinet (FN) is in focus after expanding its manufacturing partnership with iPronics to scale silicon photonics based optical circuit switch systems for AI data centers, coinciding with Fabrinet’s appearance at the Optical Fiber Communication Conference 2026. See our latest analysis for Fabrinet. Despite a 6.4% one day share price decline to US$506.27, Fabrinet’s 90 day share price return of 6.5% sits alongside a very large 1 year total shareholder return. This suggests underlying momentum...
NYSE:SKYH
NYSE:SKYHInfrastructure

Sky Harbour Group (SKYH) Profitability Shift Challenges Bearish Cash Flow Concerns

Sky Harbour Group (SKYH) closed FY 2025 with Q4 revenue of US$8.1 million and basic EPS of US$0.28, alongside trailing twelve month revenue of US$27.5 million and EPS of US$0.56 that reflect the recent shift into profitability. The company has seen quarterly revenue move from US$4.6 million in Q4 2024 to US$8.1 million in Q4 2025, while basic EPS has swung from a loss of US$0.47 to a profit of US$0.28 over the same period. This gives investors a clearer view of how top line scale and earnings...
NYSE:TXNM
NYSE:TXNMElectric Utilities

Is It Too Late To Consider TXNM Energy (TXNM) After Recent Blackstone Deal News?

Wondering if TXNM Energy at around US$58 is offering value or asking too much? This article breaks down what the current price might really mean for you. The stock has seen a 1.3% decline over the last 7 days and is down 2.0% over the past month, while still showing a 10.7% return over 1 year and 32.2% over 3 years. Recent coverage of TXNM Energy has focused on its positioning within the Electric Utilities space and how investors are reacting to the current pricing and sector sentiment. This...
NasdaqCM:DVLT
NasdaqCM:DVLTSemiconductor

Datavault AI (DVLT) Turns Q4 Profit That Challenges Persistent Loss Narrative

Datavault AI (DVLT) closed out FY 2025 with fourth quarter revenue of US$33.8 million and basic EPS of roughly US$0.00, while trailing twelve month revenue stood at US$39.1 million and basic EPS reflected a loss of US$0.52. Over recent quarters, the company has seen revenue move from US$0.9 million in Q4 2024 to US$33.8 million in Q4 2025, as quarterly EPS shifted from a loss of US$2.00 to around breakeven. This sets up a results season where rapid top line expansion sits alongside still...
NasdaqGS:DLTH
NasdaqGS:DLTHSpecialty Retail

Duluth Holdings (DLTH) Swings To Q4 Profit Challenging Persistent Loss Narratives

Duluth Holdings (DLTH) just closed FY 2026 with fourth quarter revenue of US$215.9 million and basic EPS of US$0.22, alongside net income of US$7.7 million, while the trailing twelve month figures sit at US$565.2 million of revenue and a basic EPS loss of US$0.47. Over recent quarters the company has seen revenue move from US$127.1 million in Q3 FY 2025 to US$102.7 million in Q1 FY 2026, then to US$131.7 million in Q2, US$114.9 million in Q3 and US$215.9 million in Q4. EPS shifted from a loss...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is It Too Late To Consider Nasdaq (NDAQ) After Its Strong Multi Year Run?

For readers wondering whether Nasdaq is still fairly priced after its recent run, or if there is value left on the table, this article focuses squarely on what the current share price implies. Nasdaq shares last closed at US$86.36, with returns of 1.0% over the past week, 5.1% over the past month, a 10.7% decline year to date, and gains of 15.7% over 1 year, 69.7% over 3 years, and 83.9% over 5 years. Recent coverage around Nasdaq has centered on its role as a major market infrastructure...
NYSE:CTRE
NYSE:CTREHealth Care REITs

A Look At CareTrust REIT (CTRE) Valuation After The Latest Dividend Increase

CareTrust REIT (CTRE) recently drew investor attention after its Board of Directors approved an increase in the quarterly cash dividend, raising the payout from US$0.335 to US$0.39 per common share. See our latest analysis for CareTrust REIT. Despite the higher dividend, recent share price momentum has cooled, with a 1-day share price return decline of 8.03% and a 30-day share price return decline of 10.09%. By contrast, the 1-year total shareholder return of 31.40% and 3-year total...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma Leadership Moves And Valuation Signal For Deal Pipeline

Royalty Pharma (NasdaqGS:RPRX) has expanded its leadership team with Greg Butz joining as Executive Vice President, Partnering & Investments. Chris Hite has been appointed Chairman, Partnering & Investments, adding further senior oversight to the firm’s transaction efforts. Both executives bring extensive healthcare investment banking experience aimed at strengthening Royalty Pharma’s global transactional capabilities. Royalty Pharma focuses on acquiring biopharmaceutical royalties,...
NasdaqGS:PAYX
NasdaqGS:PAYXProfessional Services

Is It Time To Reassess Paychex (PAYX) After A 33% One Year Share Price Decline?

Wondering if Paychex at around US$92.55 is starting to look interesting again, or if the stock still has more to prove before it looks attractively priced. The share price is around US$92.55, with returns of around 0.1% over the past week, 1.8% over the past month, and a 14.8% decline year to date, while the 1 year return sits at a 33.0% decline. These moves sit against a longer backdrop where the stock has returned a 6.1% gain over 5 years, with a 6.5% decline over 3 years. This highlights...